Teleflex to Spin Off Urology, Acute-Care, OEM Businesses

Dow Jones

02/27

By Colin Kellaher

Medical-technology company Teleflex said it plans to spin off its urology, acute-care and OEM businesses into an independent, publicly traded company.

Teleflex on Thursday said the remaining company, consisting of its vascular access, interventional and surgical businesses, will focus on high-growth, primarily hospital-focused emergent end markets.

The Wayne, Pa., company said it expect to complete the tax-free spinoff by mid-2026.

Teleflex said it expects the remaining company, with pro-forma 2024 revenue of about $2.1 billion, to generate constant-currency revenue growth topping 6%. The company said the spinoff had about $1.4 billion in revenue in 2024.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 27, 2025 07:42 ET (12:42 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2514801153"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514801153\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514801153?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 20:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514801153","market":"other","top_or_hot":-1,"title":"Teleflex to Spin Off Urology, Acute-Care, OEM Businesses","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Medical-technology company Teleflex said it plans to spin off its urology, acute-care and OEM businesses into an independent, publicly traded company. \n</p>\n<p>\n  Teleflex on Thursday said the remaining company, consisting of its vascular access, interventional and surgical businesses, will focus on high-growth, primarily hospital-focused emergent end markets. \n</p>\n<p>\n  The Wayne, Pa., company said it expect to complete the tax-free spinoff by mid-2026. \n</p>\n<p>\n  Teleflex said it expects the remaining company, with pro-forma 2024 revenue of about $2.1 billion, to generate constant-currency revenue growth topping 6%. The company said the spinoff had about $1.4 billion in revenue in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 27, 2025 07:42 ET (12:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Teleflex to Spin Off Urology, Acute-Care, OEM Businesses</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTeleflex to Spin Off Urology, Acute-Care, OEM Businesses\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-27 20:42</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Medical-technology company Teleflex said it plans to spin off its urology, acute-care and OEM businesses into an independent, publicly traded company. \n</p>\n<p>\n  Teleflex on Thursday said the remaining company, consisting of its vascular access, interventional and surgical businesses, will focus on high-growth, primarily hospital-focused emergent end markets. \n</p>\n<p>\n  The Wayne, Pa., company said it expect to complete the tax-free spinoff by mid-2026. \n</p>\n<p>\n  Teleflex said it expects the remaining company, with pro-forma 2024 revenue of about $2.1 billion, to generate constant-currency revenue growth topping 6%. The company said the spinoff had about $1.4 billion in revenue in 2024. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 27, 2025 07:42 ET (12:42 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2514801153","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514801153","pubTimestamp":1740660120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Medical-technology company Teleflex said it plans to spin off its urology, acute-care and OEM businesses into an independent, publicly traded company.Teleflex on Thursday said the remaining company, consisting of its vascular access, interventional and surgical businesses, will focus on high-growth, primarily hospital-focused emergent end markets.The Wayne, Pa., company said it expect to complete the tax-free spinoff by mid-2026.Teleflex said it expects the remaining company, with pro-forma 2024 revenue of about $2.1 billion, to generate constant-currency revenue growth topping 6%. The company said the spinoff had about $1.4 billion in revenue in 2024.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK4504":"桥水持仓","N0Z.SI":"联志国际","TFX":"泰利福","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"Teleflex将剥离泌尿外科、急症护理、OEM业务","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"N0Z.SI":1,"TFX":1},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Medical-technology company Teleflex said it plans to spin off its urology, acute-care and OEM businesses into an independent, publicly traded company. \n\n\n  Teleflex on Thursday said the remaining company, consisting of its vascular access, interventional and surgical businesses, will focus on high-growth, primarily hospital-focused emergent end markets. \n\n\n  The Wayne, Pa., company said it expect to complete the tax-free spinoff by mid-2026. \n\n\n  Teleflex said it expects the remaining company, with pro-forma 2024 revenue of about $2.1 billion, to generate constant-currency revenue growth topping 6%. The company said the spinoff had about $1.4 billion in revenue in 2024. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 27, 2025 07:42 ET (12:42 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}